Atrial Fibrillation Trial, Recruiting (NCT06598280)

Atrial Fibrillation Trial, Recruiting NCT06598280 Sponsor: University of Luebeck Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT06598280 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 years or older
People who are scheduled for a planned (non-emergency) catheter ablation procedure for atrial fibrillation, using specific-sized access tubes (6 to 14 Fr inner diameter) inserted into one or two veins in the groin area, regardless of the type of energy used during the procedure

Who may not be able to join:

People who have an active infection or inflammation anywhere in the body, or in the skin or tissue near the groin area
People whose blood platelet count (the cells that help blood clot) is below 50,000 cells per cubic millimetre
People whose body mass index (a measure of body weight relative to height) is either above 45 or below 18

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Roland R Tilz, Prof. Dr., Universitätsklinikum Schleswig-Holstein, Universitäres Herzzentrum Lübeck, Klinik für Rhythmologie

Phone: 0049451500

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06598280

Sponsor: University of Luebeck

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 0049451500

More information: https://clinicaltrials.gov/study/NCT06598280

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 years or older
People who are scheduled for a planned (non-emergency) catheter ablation procedure for atrial fibrillation, using specific-sized access tubes (6 to 14 Fr inner diameter) inserted into one or two veins in the groin area, regardless of the type of energy used during the procedure

Who may not be able to join:

People who have an active infection or inflammation anywhere in the body, or in the skin or tissue near the groin area
People whose blood platelet count (the cells that help blood clot) is below 50,000 cells per cubic millimetre
People whose body mass index (a measure of body weight relative to height) is either above 45 or below 18

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Luebeck

Registry

ClinicalTrials.gov

Start date

20 February 2025

Est. completion

31 December 2027

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

30 Day vascular access-related adverse events; Time to ambulation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov